Next step in antibiotic stewardship: Pharmacist-provided penicillin allergy testing

Journal of Clinical Pharmacy and Therapeutics
Z GugkaevaM Yasnogorodsky

Abstract

Penicillin allergy limits therapeutic options for patients but often disappears over time, leaving patients erroneously labelled allergic and leading to the utilization of broad-spectrum and more expensive antibiotics. Penicillin allergy can be effectively assessed via skin testing. To improve patient access to penicillin allergy testing by implementing a pharmacist-provided service in a hospital setting. Beta-lactams remain a mainstream therapy for many infections due to their effectiveness, low side effects and affordability. Typically, patient access to penicillin allergy testing is limited by the availability of allergy specialists, who traditionally perform such testing. A pharmacist-provided penicillin allergy testing service was implemented at our hospital in 2015 and became a powerful antibiotic stewardship tool. Removing penicillin allergy from patient profiles significantly expanded therapeutic options, expedited discharges and reduced costs of care. Pharmacists can expand patient access to penicillin allergy testing. Pharmacist-provided penicillin allergy testing permitted optimized antibiotic treatment and expedited discharges.

References

Jul 21, 2004·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Geoffrey C WallJames A Wille
Apr 25, 2008·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·I Leonard BernsteinUNKNOWN American College of Allergy, Asthma and Immunology
May 29, 2013·Pharmacotherapy·Nathan R UngerLinda W Cheung

❮ Previous
Next ❯

Citations

Oct 4, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eunah Cheon, Harold W Horowitz
Sep 5, 2018·Journal of Public Health Management and Practice : JPHMP·Zahava R S Rosenberg-YungerSayako Yokoyama
Apr 2, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Tyler A VestStephen F Eckel
Jun 5, 2019·Expert Review of Clinical Immunology·Natalia Blanca-LopezMiguel Blanca
Sep 21, 2019·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Anita R ModiChristopher S Kovacs
Feb 19, 2020·Current Opinion in Pediatrics·Marcus ShakerMatthew Greenhawt
Jul 15, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher M Bland, Bruce M Jones
Sep 6, 2018·Journal of Pharmacy Practice·Bryan G ShawMilena M McLaughlin
Nov 5, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Ethan Englert, Andrea Weeks
Feb 22, 2021·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Nicholas P Torney, Michael D Tiberg
Sep 29, 2021·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·Jessica K GrahamRakesh D Mistry

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Related Papers

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
P C Potter
Clinical and Investigative Medicine. Médecine Clinique Et Experimentale
Joanne M LangleyRobert Bortolussi
Journal of the American Pharmacists Association : JAPhA
Nancy Hecox
© 2022 Meta ULC. All rights reserved